Randomised trial showed that rapid rehydration of severely malnourished children with dehydrating diarrhoea was as safe and effective as slow rehydration.

AIM: This study evaluated the effectiveness and safety of rapid and slow rehydration in children aged 6-60 months with dehydrating diarrhoea and severe malnutrition. METHODS: A randomised controlled trial was conducted from July 2011 to March 2014 at the International Centre for Diarrhoeal Disease Research Bangladesh. We included children with weight for age and, or, weight for length Z-scores of less than -3 or with bipedal oedema and acute diarrhoea with severe dehydration. The children received intravenous fluid at different rates: 105 rapidly over six hours and 103 slowly over the 12 hours recommended by the World Health Organization. RESULTS: All the children were successfully rehydrated. The admittance weights were similar for the slow and rapid groups: 8.4 kg and 8.3 kg. After 24 hours, the mean percentage weight gain was 8.5% and 9.0%, respectively. This confirmed that most of the children had been suffering from severe dehydration on admission. The respective proportions of children who received unscheduled intravenous fluid were 18% and 17%. None developed fluid overload or heart failure and most recovered normal renal function after rehydration. CONCLUSION: Rapid rehydration saved time, was as safe as slow rehydration and was a better option for dehydrating diarrhoea and severe malnutrition.

Knowledge, attitude and practices towards SARS-CoV-2 genetic mutations and emerging variants among the population in Bangladesh: a cross-sectional study.

OBJECTIVES: The coronavirus is continuously mutating and creating new SARS-CoV-2 variants. Public awareness about SARS-CoV-2 mutation is essential for effective preventive measures. The present study aimed to assess the knowledge, attitude and practices (KAP) towards SARS-CoV-2 variants among the general population in Bangladesh. DESIGN: We conducted this online survey between 9 April 2021 and 10 May 2021 using structured questionnaires to collect the information. SETTING: We distributed the survey link among the participants from all 64 districts of Bangladesh using social media platforms. PARTICIPANTS: A total of 1,090 respondents completed this survey. After careful evaluation, we excluded 18 responses due to partial or incomplete information, and 1,072 responses entered into the final analysis. PRIMARY OUTCOME: The KAP of participants towards SARS-CoV-2 variants depends on their demographic backgrounds. Associations between demographic characteristics and the likelihood of having adequate KAP were estimated using adjusted logistic regressions. RESULTS: Among the participants, 42% had a poor knowledge level, 4% had a low attitude level and 14% had a poor practice score. The average knowledge, attitude and practice score were 2.65, 4.194 and 4.464 on a scale of 5, respectively. Only 51.8% of the participants knew about mutant strains, and only 47.6% knew about the effectiveness of vaccines against new variants. The key factors associated with poor knowledge levels were educational levels, area of residence, geographic location, and concern regarding COVID-19. Sociodemographic factors for poor attitude levels were geographic location, vaccination and concern regarding COVID-19. The pivotal factors in determining poor practice scores were the residence area of people and concern regarding COVID-19. CONCLUSIONS: The knowledge level and positive attitude are associated with better preventive measures against SARS-CoV-2 variants. Based on these findings, we recommended several awareness programmes on SARS-CoV-2 mutations and variants for the rural population in Bangladesh to increase overall awareness levels.

Evaluation of yield attributes and bioactive phytochemicals of twenty amaranth genotypes of Bengal floodplain.

Twenty vegetable amaranth (VA) genotypes were evaluated to assess the variability, associations, path coefficient, and principal component analysis (PCA) of morpho-chemical traits. The genotypes exhibited adequate antioxidant colorants, phytochemicals, and antiradical capacity with significant variations across genotypes. Genetic parameters revealed selection criteria for the majority of the traits for improving amaranth foliage yield (FY). Based on correlation coefficient, stem weight, stem base diameter, root weight, plant height, and shoot weight for significant development of FY of VA. Observing significant genotypic correlation with high positive direct effects on FY, the path coefficient (PC) of root weight, stem base diameter, stem weight, and shoot weight could contribute to the noteworthy development of FY of VA. The genotypes AA5, AA6, AA8, AA10, AA11, AA19, and AA20 might be selected for high FY, antioxidant colorants, and antiradical phytochemicals to utilize as colorants and antiradical rich superior high yielding cultivars. The first PC accounted for 37.8% of the variances, which implies a larger proportion of variable information explained by PC1. The features that contributed more to PC1 were FY, SW, STW, RW, and PH, whereas Chl b, total Chl, and Chl a contributed to the second PC. This suggests that there are significant genetic differences between amaranths in terms of biochemical and agro-morphological characteristics. The findings of the current work support plant breeders to investigate the genetic potential of the amaranth germplasm, notably in biochemical parameters. High colorants enrich genotypes that can be selected for extracting natural colorants to use in food processing industries.

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study.

In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the side effects that were experienced by the Bangladeshi residents after receiving the first dose of the Oxford-AstraZeneca's Covishield vaccine (ChAdOx1nCoV-19). The study was conducted using both online and printed questionnaires and the data were analysed using SPSS. The results included the responses of 474 vaccine recipients from March-April 2021. Pain at the site of injection, fever, myalgia, fatigue and headache were the most commonly reported symptoms, and the overall side effects were found to be significantly more prevalent in the younger population (p ≤ 0.05). These findings were consistent with the results indicated by the clinical trial of ChAdOx1nCoV-19. Logistic regression analysis further revealed that compared to people aged 70 years or above, the incidence of reported side effects was significantly higher in people aged 18-30 years (odds ratio (OR) = 8.56), 31-40 years, (OR = 5.05), 41-50 years (OR = 4.08), 51-60 years (OR = 3.77) and 61-70 years (OR = 3.67). In addition, a significantly higher percentage of female participants suffered from post-vaccination side effects compared to males (OR = 1.51). It was concluded that the Covishield vaccine was well-tolerated among people of different age groups. Nevertheless, further long-term follow-up study with a larger sample size is warranted to establish the long-term safety of the COVID-19 vaccine.